Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRT vs MRNA✓SelectedUSD · MRNAVRT vs MRNA performance historyLatest closeAs of-6.63%11/16
Stock and ETF performance explorer

VRT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+342.1%
MRNA return
+182.7%
Excess return
+159.4%
Maximum drawdown
-61.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.6%-3.6%-3.0%-6.5%
7D-5.9%-20.0%+14.1%-5.3%
30D-8.6%-1.3%-7.3%-8.5%
3M-35.8%+240.0%-275.7%-38.8%
6M-49.1%+339.0%-388.1%-54.1%
YTD+16.5%+630.0%-613.4%-4.4%
1Y+10.5%+769.1%-758.6%-12.1%
3Y+342.1%+181.2%+160.9%+320.6%
All+342.1%+182.7%+159.4%+320.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling